semaglutide for parkinson's GLP-1 drug shows little benefit people with disease | UCL News Use of new diet drugs

Understanding the indications and contraindications helps you make an informed decision with your healthcare provider

And, while this particular side effect also appears rare, an association is being established in studies of patients taking GLP-1 receptor agonists

[ Links ] Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD (1994) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

Palmitoylation of SARS-CoV S protein is necessary for partitioning into detergent-resistant membranes and cell-cell fusion but not interaction with M protein